rs372975881

Variant names:

Your query was ambiguous. Multiple possible variants found:

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001242896.3(DEPDC5):c.2019C>G(p.Ser673Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000508 in 1,613,964 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S673S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)

Exomes 𝑓: 0.000055 ( 0 hom. )

Consequence

DEPDC5
NM_001242896.3 synonymous

Scores

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.303

Publications

0 publications found

Variant links:

Genes affected

DEPDC5 (HGNC:18423): (DEP domain containing 5, GATOR1 subcomplex subunit) This gene encodes a member of the IML1 family of proteins involved in G-protein signaling pathways. The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates cell growth by sensing the availability of nutrients. The protein encoded by this gene is a component of the GATOR1 (GAP activity toward Rags) complex which inhibits the amino acid-sensing branch of the mTORC1 pathway. Mutations in this gene are associated with autosomal dominant familial focal epilepsy with variable foci. A single nucleotide polymorphism in an intron of this gene has been associated with an increased risk of hepatocellular carcinoma in individuals with chronic hepatitis C virus infection. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]

DEPDC5 Gene-Disease associations (from GenCC):

epilepsy, familial focal, with variable foci 1
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, Illumina, G2P
focal epilepsy
Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
autosomal dominant epilepsy with auditory features
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
autosomal dominant nocturnal frontal lobe epilepsy
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
familial focal epilepsy with variable foci
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Brugada syndrome
Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

DEPDC5 links:

ENSG00000285404 (HGNC:):

ENSG00000285404 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4

Computational evidence support a benign effect (REVEL=0.069).

BP6

Variant 22-31822705-C-G is Benign according to our data. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-31822705-C-G is described in CliVar as Likely_benign. Clinvar id is 534819.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BP7

Synonymous conserved (PhyloP=0.303 with no splicing effect.

BS1

Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0000554 (81/1461774) while in subpopulation MID AF = 0.00104 (6/5760). AF 95% confidence interval is 0.000453. There are 0 homozygotes in GnomAdExome4. There are 40 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check.

BS2

High AC in GnomAdExome4 at 81 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
DEPDC5	NM_001242896.3 link	c.2019C>G	p.Ser673Ser	synonymous_variant	Exon 24 of 43	ENST00000651528.2	NP_001229825.1	O75140-10

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
DEPDC5	ENST00000651528.2 link	c.2019C>G	p.Ser673Ser	synonymous_variant	Exon 24 of 43		NM_001242896.3	ENSP00000498382.1		O75140-10
ENSG00000285404	ENST00000646701.1 link	c.1786+3480C>G		intron_variant	Intron 20 of 20			ENSP00000496158.1		A0A2R8YF50

Frequencies

GnomAD3 genomes

AF:

0.00000657

AC:

AN:

152190

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.00

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.0000655

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.00

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.0000562

AC:

AN:

249144

AF XY:

0.0000666

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.000174

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.0000620

Gnomad OTH exome

AF:

0.000165

GnomAD4 exome

AF:

0.0000554

AC:

AN:

1461774

Hom.:

Cov.:

AF XY:

0.0000550

AC XY:

AN XY:

727174

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

33480

American (AMR)

AF:

0.000179

AC:

AN:

44720

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

26134

East Asian (EAS)

AF:

0.00

AC:

AN:

39694

South Asian (SAS)

AF:

0.0000116

AC:

AN:

86240

European-Finnish (FIN)

AF:

0.00

AC:

AN:

53406

Middle Eastern (MID)

AF:

0.00104

AC:

AN:

5760

European-Non Finnish (NFE)

AF:

0.0000585

AC:

AN:

1111954

Other (OTH)

AF:

0.0000166

AC:

AN:

60386

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.453

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.00000657

AC:

AN:

152190

Hom.:

Cov.:

AF XY:

0.0000135

AC XY:

AN XY:

74336

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

41454

American (AMR)

AF:

0.0000655

AC:

AN:

15274

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3472

East Asian (EAS)

AF:

0.00

AC:

AN:

5194

South Asian (SAS)

AF:

0.00

AC:

AN:

4812

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10618

Middle Eastern (MID)

AF:

0.00

AC:

AN:

316

European-Non Finnish (NFE)

AF:

0.00

AC:

AN:

68046

Other (OTH)

AF:

0.00

AC:

AN:

2092

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.575

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.0000565

Hom.:

Bravo

AF:

0.0000302

EpiCase

AF:

0.000164

EpiControl

AF:

0.000237

ClinVar

Significance: Likely benign

Submissions summary: Benign:4

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

not provided

Benign:2

Sep 01, 2021

CeGaT Center for Human Genetics Tuebingen

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Dec 06, 2019

GeneDx

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Inborn genetic diseases

Benign:1

Jan 31, 2017

Ambry Genetics

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Familial focal epilepsy with variable foci

Benign:1

Oct 21, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.36

CADD

Benign

7.0

(source)

DANN

Benign

0.73

PhyloP100

0.30

Mutation Taster

=99/1

polymorphism

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over